How big is the Estonia Pharmaceutical Market?

The Estonia Pharmaceutical Market size is expected to reach USD 528.14 million in 2024 and grow at a CAGR of 6.55% to reach USD 725.29 million by 2029. Read More

What is the current Estonia Pharmaceutical Market size?

In 2024, the Estonia Pharmaceutical Market size is expected to reach USD 528.14 million. Read More

Who are the key players in Estonia Pharmaceutical Market?

AbbVie Inc., AstraZeneca plc, Bayer AG, C.H. Boehringer Sohn AG & Ko. KG and GlaxoSmithKline plc are the major companies operating in the Estonia Pharmaceutical Market. Read More

What years does this Estonia Pharmaceutical Market cover, and what was the market size in 2023?

In 2023, the Estonia Pharmaceutical Market size was estimated at USD 493.55 million. The report covers the Estonia Pharmaceutical Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Estonia Pharmaceutical Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Estonia Pharmaceutical Market Size & Share Analysis - Industry Research Report

Estonia Pharmaceutical Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Estonia Pharmaceutical Market is Segmented by Therapeutic Category (Anti-Infectives, Cardiovascular, Gastrointestinal, Anti-Diabetic, Respiratory, Dermatological, Musculoskeletal System, Nervous System, and Other Therapeutic Categories) and Drug Type (Prescription Drugs (Branded Drugs and Generic Drugs) and OTC Drugs). For Each Segment, The Market Size and Forecast are Provided in Terms of Value (USD).

Estonia Pharmaceutical Industry Overview

The Estonian pharmaceutical market is competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are actively making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Key companies currently dominating the market include AbbVie Inc., AstraZeneca PLC, Bayer AG, C H Boehringer Sohn AG & Co. KG, and GlaxoSmithKline PLC.